APOE genotype influences functional status among elderly without dementia
- 18 December 1995
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 60 (6) , 583-587
- https://doi.org/10.1002/ajmg.1320600621
Abstract
The presence of apolipoprotein‐ϵ4 (APOE‐ϵ4) significantly increases the risk of Alzheimer's disease (AD). The association between APOE‐ϵ4 status and functional abilities was explored further in a multicultural sample of community‐dwelling, non‐demented elders. The sample was limited to cognitively‐intact, community‐dwelling elders, who were free of stroke or other neurologic disability. In 218 elders who met research criteria, the presence of APO‐ϵ4 was associated with poorer functional status, apart from the effects of neuropsychological performance, gender, age, and education (OR = 2.5, 95% CI: 1.3, 4.9). In 158 subjects without an APOE‐ϵ4 allele, 50% reported no functional limitation; in the 60 subjects with an ϵ4 allele, only 28% reported no functional limitation (P < .01). The relationship was not explained by the distribution of co‐morbidities. The association between poorer function and the presence of an APOE‐ϵ4 allele was evident in each ethnic group. In path analyses, the presence of an APOE‐ϵ4 allele was associated with decreased functional ability in non‐demented elders not simply through an association with poorer cognitive status, but also independently. These results suggest that the APOE‐ϵ4 genotype is associated with functional deficit in people with normal neuropsychological profiles.Keywords
This publication has 24 references indexed in Scilit:
- Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African AmericansAnnals of Neurology, 1995
- Clinical application of apolipoprotein E genotyping to Alzheimer's diseaseThe Lancet, 1994
- Apolipoprotein E in animal models of CNS injury and in alzheimer's diseaseTrends in Neurosciences, 1994
- Genetic associations with human longevity at the APOE and ACE lociNature Genetics, 1994
- Apolipoprotein E ∈4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseasesThe Lancet, 1993
- Apolipoprotein E polymorphism and Alzheimer's diseaseThe Lancet, 1993
- Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset FamiliesScience, 1993
- Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease. A case-control study.Stroke, 1993
- A New Clinical Scale for the Staging of DementiaThe British Journal of Psychiatry, 1982
- The Association Between Quantitative Measures of Dementia and of Senile Change in the Cerebral Grey Matter of Elderly SubjectsThe British Journal of Psychiatry, 1968